# HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.

Study · id `cardio:ct-nct07233070` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07233070](<https://clinicaltrials.gov/study/NCT07233070>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07233070

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 210 participants.

## Technical summary

Registry record NCT07233070. Randomized; quadruple masking; primary purpose treatment. Start 2025-10-31 (actual); primary completion 2026-09-17 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 210 participants (enrolled count; ClinicalTrials.gov record NCT07233070, source copy `cardio:ctgov-nct07233070-2026-10-20`, retrieved 2026-10-26)
- Started: 2025-10-31 (actual) (ClinicalTrials.gov record NCT07233070, source copy `cardio:ctgov-nct07233070-2026-10-20`, retrieved 2026-10-26)
- Primary completion: 2026-09-17 (actual) (ClinicalTrials.gov record NCT07233070, source copy `cardio:ctgov-nct07233070-2026-10-20`, retrieved 2026-10-26)
- Completion: 2026-09-17 (actual) (ClinicalTrials.gov record NCT07233070, source copy `cardio:ctgov-nct07233070-2026-10-20`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07233070, source copy `cardio:ctgov-nct07233070-2026-10-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07233070-2026-10-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.
- Condition: Acute Ischemic Stroke
- Intervention (Drug): HRS-7450 Injection
- Intervention (Drug): HRS-7450 Injection
- Intervention (Drug): HRS-7450 Injection
- Intervention (Drug): HRS-7450 Injection Placebo
- Lead sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. (`cardio:org-fujian-shengdi-pharmaceutical-co-ltd`)

## Provenance

Content hash: a557166b9b541ea57879ee83a6aee09c7b04868d138832aba36b7c7b8472f5b2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
